The Benefits of Telehealth for Cystic Fibrosis Patients
A recent survey of clinicians from several cystic fibrosis centers found that cystic fibrosis care via telehealth improved efficiency and is well accepted by providers.
Category: Cystic fibrosis
Cystic fibrosis
Latest
Cystic fibrosis
Latest
Antifungal Drug Improves Cystic Fibrosis Biomarkers
A drug used to treat fungal infections improved key biomarkers in lung tissue cultures of patients with cystic fibrosis.
Cystic fibrosis
Latest
FDA Grants Pediatric Disease Designations to Spirovant’s New Cystic Fibrosis Therapy
Spirovant Sciences announced that the FDA has granted Orphan Drug and Rare Pediatric Disease Designations to its lead product candidate, SPIRO-2101, for cystic fibrosis treatment.
Cystic Fibrosis: Phase 1B Trial Begins for Arginase Inhibitor
Calithera Biosciences Inc has dosed the first patients in its Phase 1b clinical trial of the arginase inhibitor CB-280 in adult patients with cystic fibrosis and chronic airway infection.
Read More
Scientists Build Computer Model to Understand the Genetics of Cystic Fibrosis
Researchers at the University of Virginia School of Engineering and other across the country are working on a computer model to understand which genes cause cystic fibrosis and other diseases.
Read More
Protein at the Root of Cystic Fibrosis Infections
Swiss researchers highlight how the protein Vav3 creates bacterial docking stations to facilitate lung infections in cystic fibrosis.
Read More
Cystic Fibrosis Patients May Have a Lower Incidence of COVID-19
Research from a study in Respiratory Medicine found that patients with cystic fibrosis (CF) may have a lower rate of the novel coronavirus compared to the general population.
Read More
Vertex’s Cystic Fibrosis Pill Gets European Medicines Agency’s Backing
Vertex Pharmaceutical’s triple combination cystic fibrosis treatment, Kaftrio, is one step closer to coming to market after receiving a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).
Read More
Study: Tobacco Smoke and Cystic Fibrosis
New research uncovered that tobacco smoke can inhibit the therapeutic benefit of the cystic fibrosis transmembrane conductance regulator (CFTR) modulators in children.
Read More
Classic Car Raffle to Support Cystic Fibrosis Research
On June 27 the Ohio Cobra Club will raffle a replica Shelby 427 Cobra to raise funding for research at the Cystic Fibrosis Foundation.
Read More
New York Ends Cystic Fibrosis Financial Assistance Program
New York State’s Adult Cystic Fibrosis Assistance Program (ACFAP) was defunded and will no longer be reimbursing CF patients for medical expenses.
Read MoreCF Foundation Supporting Development of Malabsorption Syndrome Therapy
The Cystic Fibrosis Foundation is supporting the development of Synspira’s SNSP003, an orally-delivered non-porcine enzyme replacement therapy (ERT) designed to treat malabsorption syndromes.
Read More
Gut Microbe Imbalance May Stunt Cystic Fibrosis Babies’ Growth
The composition of the gut microbiome may make a difference in height gain in infants with cystic fibrosis during their first year of life, according to a new study.
Read More
Cystic Fibrosis: Antibiotic Combo Killed M. abscessus Bacteria
A new treatment that combines three antibiotics safely eradicated Mycobacterium abscessus (M. abscessus) bacteria extracted from cystic fibrosis lungs.
Read More
Survey: Cystic Fibrosis Patients Receiving CFTR Modulators Had More Positive Health Outlooks
Cystic fibrosis patients being treated with a CFTR modulator had more positive outlooks on their futures, treatment plans, and healthcare professionals.
Read More